These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8956077)

  • 21. Conformational analysis of enkephalin analogs containing a disulfide bond. Models for delta- and mu-receptor opioid agonists.
    Froimowitz M; Hruby VJ
    Int J Pept Protein Res; 1989 Aug; 34(2):88-96. PubMed ID: 2553632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solution conformation of [D-Pen2, D-Pen5] enkephalin in water: a NMR and molecular dynamics study.
    Gussmann M; Borsdorf R; Hofmann HJ
    J Pept Sci; 1996; 2(6):351-6. PubMed ID: 9230462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1H n.m.r. investigation of conformational features of cyclic enkephalinamide analogs.
    Mosberg HI; Schiller PW
    Int J Pept Protein Res; 1984 May; 23(5):462-6. PubMed ID: 6735586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the bioactive form and molecular determinants of recognition of cyclic enkephalin peptides at the delta-opioid receptor.
    Chew C; Villar HO; Loew GH
    Biopolymers; 1993 Apr; 33(4):647-57. PubMed ID: 8385507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
    Chao TM; Perez JJ; Loew GH
    Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mimicry of beta II'-turns of proteins in cyclic pentapeptides with one and without D-amino acids.
    Weisshoff H; Präsang C; Henklein P; Frömmel C; Zschunke A; Mügge C
    Eur J Biochem; 1999 Feb; 259(3):776-88. PubMed ID: 10092864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and solution conformation of c(D-Trp-D-Cys(SO3-Na+)-Pro-D-Val-Leu), a potent endothelin-A receptor antagonist.
    Bogusky MJ; Brady SF; Sisko JT; Nutt RF; Smith GM
    Int J Pept Protein Res; 1993 Aug; 42(2):194-203. PubMed ID: 8407113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic space structure of the Leu-enkephalin molecule in DMSO solution.
    Vesterman B; Saulitis J; Betins J; Liepins E; Nikiforovich GV
    Biochim Biophys Acta; 1989 Oct; 998(2):204-9. PubMed ID: 2790063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational analysis of cyclic partially modified retro-inverso enkephalin analogues by proton NMR.
    Mammi NJ; Goodman M
    Biochemistry; 1986 Nov; 25(23):7607-14. PubMed ID: 3801437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions.
    Chandrakumar NS; Stapelfeld A; Beardsley PM; Lopez OT; Drury B; Anthony E; Savage MA; Williamson LN; Reichman M
    J Med Chem; 1992 Aug; 35(16):2928-38. PubMed ID: 1323677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformation of CD4-derived cyclic hexapeptides by NMR and molecular dynamics.
    Ma S; McGregor MJ; Cohen FE; Pallai PV
    Biopolymers; 1994 Aug; 34(8):987-1000. PubMed ID: 8075393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of conformational equilibria in aplidine using selective excitation 2D NMR spectroscopy and molecular mechanics/dynamics calculations.
    Cárdenas F; Caba JM; Feliz M; Lloyd-Williams P; Giralt E
    J Org Chem; 2003 Dec; 68(25):9554-62. PubMed ID: 14656079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational determinants of high affinity delta receptor binding of opioid peptides.
    Keys C; Payne P; Amsterdam P; Toll L; Loew G
    Mol Pharmacol; 1988 May; 33(5):528-36. PubMed ID: 2835652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental simulation of the environment of the delta opioid receptor. A 500 MHz study of enkephalins in CDCl3.
    Beretta CA; Parrilli M; Pastore A; Tancredi T; Temussi PA
    Biochem Biophys Res Commun; 1984 Jun; 121(2):456-62. PubMed ID: 6329204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide.
    Heyl DL; Omnaas JR; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
    Int J Pept Protein Res; 1991 Mar; 37(3):224-9. PubMed ID: 1651290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Conformation of D-Orn2-containing cycloanalogs of enkephalins in dimethylsulfoxide solution].
    Shenderevich MD; Saulitis IuB; Bobrova IV; Puchina AV; Abissova NA; Nikiforovich GV; Chipens GI
    Bioorg Khim; 1990 Jan; 16(1):21-33. PubMed ID: 2346514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C; Brandt W; Schmidt R; Neubert K; Schiller PW
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
    Kawasaki AM; Knapp RJ; Kramer TH; Walton A; Wire WS; Hashimoto S; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    J Med Chem; 1993 Mar; 36(6):750-7. PubMed ID: 8096246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity.
    Berezowska I; Chung NN; Lemieux C; Wilkes BC; Schiller PW
    J Med Chem; 2007 Mar; 50(6):1414-7. PubMed ID: 17315860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.